Anterix Inc. (NASDAQ: ATEX) OKs stock plan share increase and all proposals
Rhea-AI Filing Summary
Anterix Inc. held its 2026 Annual Meeting of Stockholders virtually on August 4, 2026, with a quorum of 17,347,869 shares of common stock represented, or 90.06% of the 19,261,270 shares issued, outstanding and eligible to vote as of the June 11, 2026 record date.
Stockholders approved Amendment No. 2 to the Anterix Inc. 2023 Stock Plan, increasing the shares of common stock available for issuance under the plan by 1.0 million shares. All seven director nominees were elected. On a non-binding, advisory basis, stockholders approved executive compensation and supported holding future say-on-pay votes every one year. Stockholders also ratified the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending March 31, 2027.
Positive
- None.
Negative
- None.
Filing Explained
The August 4 approval expands the 2023 Plan’s capacity by
8-K Event Classification
3 items: 5.02, 5.07, 9.01
3 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Increase in 2023 Stock Plan share pool: 1.0 million shares
Shares outstanding eligible to vote: 19,261,270 shares
Shares represented at Annual Meeting: 17,347,869 shares
+4 more
7 metrics
Increase in 2023 Stock Plan share pool
1.0 million shares
Additional common stock available for issuance under the 2023 Stock Plan via Amendment No. 2
Shares outstanding eligible to vote
19,261,270 shares
Common stock issued, outstanding and eligible to vote as of June 11, 2026 record date
Shares represented at Annual Meeting
17,347,869 shares
Common stock present in person or by proxy at the August 4, 2026 Annual Meeting
Meeting quorum percentage
90.06%
Portion of eligible common stock represented at the 2026 Annual Meeting
Say-on-pay FOR votes
14,641,617
Votes cast in favor of advisory approval of named executive officer compensation
Plan Amendment FOR votes
13,558,280
Votes cast in favor of Amendment No. 2 to the Anterix Inc. 2023 Stock Plan
Auditor ratification FOR votes
17,331,529
Votes cast to ratify Deloitte & Touche LLP for the fiscal year ending March 31, 2027
Key Terms
non-binding, advisory basis, broker non-votes, record date, independent registered public accounting firm, +1 more
5 terms
non-binding, advisory basis regulatory
"stockholders approved, on a non-binding, advisory basis, the compensation"
A non-binding, advisory basis means a recommendation or decision that carries no legal force and does not obligate the parties to act; it’s similar to a friendly suggestion rather than a signed promise. For investors, this matters because such guidance can influence market expectations and management plans but offers no guarantee of follow-through, so investors should treat it as informative input rather than a firm commitment.
broker non-votes regulatory
"the number of “ABSTENTIONS” and “BROKER NON-VOTES” for each nominee"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
record date regulatory
"eligible to vote as of the record date on June 11, 2026"
The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.
independent registered public accounting firm regulatory
"appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
Stock Plan financial
"Amendment No. 2 to the Anterix Inc. 2023 Stock Plan"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What change to the 2023 Stock Plan did Anterix Inc. (ATEX) stockholders approve?
Anterix stockholders approved Amendment No. 2 to the 2023 Stock Plan, increasing the shares of common stock available for issuance under the plan by 1.0 million shares, as recommended by the board of directors.
Did Anterix (ATEX) stockholders approve executive compensation at the meeting?
Yes. On a non-binding, advisory basis, stockholders approved the compensation of Anterix’s named executive officers, with 14,641,617 votes "FOR", 15,894 "AGAINST" and 1,847 abstentions, plus 2,688,511 broker non-votes recorded.
How often will Anterix (ATEX) hold future advisory votes on executive pay?
Stockholders supported a one-year frequency for future advisory votes on named executive officer compensation, with 14,425,357 votes for one year, compared with 12,775 for two years and 219,765 for three years.
Which audit firm did Anterix (ATEX) stockholders ratify for fiscal 2027?
Stockholders ratified Deloitte & Touche LLP as Anterix’s independent registered public accounting firm for the fiscal year ending March 31, 2027, with 17,331,529 votes "FOR", 618 "AGAINST" and 15,722 abstentions.
Were all Anterix (ATEX) director nominees elected at the 2026 Annual Meeting?
Yes. All seven nominees—Jeffrey A. Altman, Leslie B. Daniels, Mark A. Fleischhauer, William E. Heard, Thomas R. Kuhn, Scott A. Lang and Mahvash Yazdi—received more "FOR" than "AGAINST" votes and were elected as directors.